Cite
Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma.
MLA
Ge, Xin, et al. “Fumarate Inhibits PTEN to Promote Tumorigenesis and Therapeutic Resistance of Type2 Papillary Renal Cell Carcinoma.” Molecular Cell, vol. 82, no. 7, Apr. 2022, p. 1249. EBSCOhost, https://doi.org/10.1016/j.molcel.2022.01.029.
APA
Ge, X., Li, M., Yin, J., Shi, Z., Fu, Y., Zhao, N., Chen, H., Meng, L., Li, X., Hu, Z., Zhao, X., Guo, H., & Qian, X. (2022). Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma. Molecular Cell, 82(7), 1249. https://doi.org/10.1016/j.molcel.2022.01.029
Chicago
Ge, Xin, Mengdie Li, Jianxing Yin, Zhumei Shi, Yao Fu, Ningwei Zhao, Hongshan Chen, et al. 2022. “Fumarate Inhibits PTEN to Promote Tumorigenesis and Therapeutic Resistance of Type2 Papillary Renal Cell Carcinoma.” Molecular Cell 82 (7): 1249. doi:10.1016/j.molcel.2022.01.029.